A Clinical Study of Fundus Findings in Toxaemia of Pregnancy

March 10, 2017 updated by: Dr.Rahul Navinchandra Bakhda MS., B. J. Medical College, Ahmedabad

A Clinical Study of Fundus Findings in Toxaemia of Pregnancy (Pregnancy Induced Hypertension)

Toxemia of pregnancy is a recognized entity for over 2000 years with its known complications and fatality. Nowadays, a most accepted terminology for the following defined syndrome is "hypertensive disorders in pregnancy" given by American College of Obstetrics and Gynecology. It is an important cause of maternal and fetal morbidity and mortality. Pregnancy induced hypertension (PIH) was classified as gestational hypertension, preeclampsia, severe preeclampsia and eclampsia. PIH is a hypertensive disorder in pregnancy that occurs after 20 weeks of pregnancy in the absence of other causes of elevated blood pressure (BP) (BP >140/90 mmHg measured two times with at least of 4 hour interval) in combination with generalized edema and/or proteinuria (>300 mg per 24 hrs). When there is significant proteinuria it is termed as preeclampsia; seizure or coma as a consequence of PIH is termed as eclampsia. Preeclampsia was classified into mild and severe preeclampsia.

Mild eclampsia-BP >140/90 mmHg, proteinuria+, and/or mild edema of legs, Severe preeclampsia-BP >160/110 mmHg,proteinuria++ or ++++, headache, cerebral or visual disturbances, epigastric pain, impaired liver function tests and increase in serum creatinine.

Proteinuria was tested using dipstick method as +=0.3 gm/L, ++=1 gm/L, and +++=3 gm/L.

The pathological changes of this disease appear to be related to vascular endothelial dysfunction and its consequences (generalized vasospasm and capillary leak). Ocular involvement is common in PIH.Common symptoms are blurring of vision, photopsia, scotomas and diplopia. Visual symptoms may be the precursor of seizures.Progression of retinal changes correlates with progression of PIH and also with the fetal mortality due to similar vascular ischemic changes in placenta.Vasospastic manifestations are reversible and the retinal vessels rapidly return to normal after delivery. Ophthalmoscope should be rated next to the sphygmomanometer as an instrument of diagnostic importance in cases of PIH. Ophthalmoscopy does not only helps in diagnosing the disease but repeated observations assist in assessing the severity, progress of disease, response to treatment if any and ultimate outcome or prognosis.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

An observational study in which the patients for the study are selected from antenatal clinic, antenatal ward and "preeclampsia and eclampsia room" in Department of Obstetrics and Gynecology and general Ophthalmic Out Patient Department(OPD) in case of ambulatory patients during the period of November 2003 to June 2006 randomly.In every case, detail obstetric history including a detail antenatal history was taken. General examination and relevant pathological investigations like routine blood count, HIV, HBsAg, renal function tests, TORCH complex etc., were carried out. In every case, pupil was dilated with homatropine (2%) eye drops. Then detailed ophthalmic examination was carried out with special emphasis on direct ophthalmoscopy apart from visual acuity of both eyes and anterior segment examination. Fundus findings were noted in detail, changes in the color of the disc, disc margin, physiological cup, changes in retinal blood vessels especially caliber of vessels, arterio-venous (AV) ratio,changes in vessel wall, blood column, appearance of vascular light reflex, changes at AV crossings, changes in macular area and changes in background, overall appearance, presence of hemorrhages, exudates or any pathology were recorded.

Fundus changes were graded as per modified Keith, Wagner and Barker classification.Assessment of prognosis as regards to vision and life (mortality) was made.

Study Type

Observational

Enrollment (Actual)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gujarat.
      • Ahmedabad, Gujarat., India, 380016
        • M and J Western Regional Institute of Ophthalmology, B.J.Medical College and Civil Hospital Campus, Ahmedabad-380016.Gujarat. 07922680360 07922680314 Fax:07922680360

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 42 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

An observational study in which the patients for the study are selected from antenatal clinic, antenatal ward and "preeclampsia and eclampsia room" in Department of Obstetrics and Gynecology and general ophthalmic OPD in case of ambulatory patients during the period of November 2003 to June 2006 randomly.

Description

Inclusion Criteria:

  • Cases of Pregnancy Induced Hypertension.

Exclusion Criteria:

  • Cases complicated by malignancy, renal, liver or other secondary manifestations.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Other

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Clinical ophthalmoscopy in PIH
An observational study in which the patients for the study are selected from antenatal clinic, antenatal ward and "preeclampsia and eclampsia room" in Department of Obstetrics and Gynecology and general ophthalmic OPD in case of ambulatory patients during the period of November 2003 to June 2006 randomly.
To study the role of clinical ophthalmoscopy in PIH in diagnosis, prognosis, differential diagnosis, line of treatment and effect of treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The relation of positive fundus changes with number of cases of pregnancy induced hypertension
Time Frame: Nov. 2003 to June 2006 randomly
Correlation of fundus changes with disease entity.In every case detail obstetric history, general examination and relevant pathological investigations were carried out. In every case, pupil was dilated with homatropine (2%) eye drops and detailed ophthalmic examination was carried out.
Nov. 2003 to June 2006 randomly
The relation of number of cases of PIH and positive fundus findings with number of gravida
Time Frame: Nov. 2003 to June 2006 randomly
Correlation of fundus changes with gravida.
Nov. 2003 to June 2006 randomly
Relationship between total number of cases of PIH and fundus changes according to age
Time Frame: Nov. 2003 to June 2006 randomly
Correlation of fundus changes with age.
Nov. 2003 to June 2006 randomly
Relationship between number of cases of PIH and fundus changes according to duration of pregnancy
Time Frame: Nov. 2003 to June 2006 randomly
Correlation of fundus changes with duration of pregnancy
Nov. 2003 to June 2006 randomly
The relation of number of cases of PIH and fundus findings with systolic blood pressure
Time Frame: Nov. 2003 to June 2006 randomly

In every case detail obstetric history, general examination and relevant pathological investigations were carried out. In every case, pupil was dilated with homatropine (2%) eye drops and detailed ophthalmic examination was carried out.

Fundus findings were noted in detail.

Nov. 2003 to June 2006 randomly
The relation of number of cases of PIH and fundus findings with diastolic blood pressure
Time Frame: Nov. 2003 to June 2006 randomly

In every case detail obstetric history, general examination and relevant pathological investigations were carried out. In every case, pupil was dilated with homatropine (2%) eye drops and detailed ophthalmic examination was carried out.

Fundus findings were noted in detail.

Nov. 2003 to June 2006 randomly
The relation of number of cases of PIH according to fundus changes (according to modified Keith, Wagner and Barker classification)
Time Frame: Nov. 2003 to June 2006 randomly

In every case detail obstetric history, general examination and relevant pathological investigations were carried out. In every case, pupil was dilated with homatropine (2%) eye drops and detailed ophthalmic examination was carried out.

Fundus findings were noted in detail.

Nov. 2003 to June 2006 randomly
The relation of individual fundus findings with no. of cases of PIH
Time Frame: Nov. 2003 to June 2006 randomly
Significance of individual fundus changes were noted
Nov. 2003 to June 2006 randomly

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Distribution of PIH cases on fetal outcome
Time Frame: Nov. 2003 to June 2006 randomly
Assessment of prognosis as regards to vision and life (mortality) was made.i.e correlation of fundus changes with fetal outcome.
Nov. 2003 to June 2006 randomly
The relation of fundus changes with perinatal mortality
Time Frame: Nov. 2003 to June 2006 randomly
Assessment of prognosis as regards to vision and life (mortality) was made.i.e correlation of fundus changes with fetal outcome and perinatal mortality.
Nov. 2003 to June 2006 randomly

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dr.Rahul Bakhda, M.S., Ex-Resident,M and J Western Regional Institute of Ophthalmology, B.J.Medical College and Civil Hospital Campus, Ahmedabad-380016.Gujarat. 07922680360 07922680314 Fax:07922680360

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2003

Primary Completion (Actual)

June 1, 2006

Study Completion (Actual)

June 1, 2006

Study Registration Dates

First Submitted

October 30, 2016

First Submitted That Met QC Criteria

March 6, 2017

First Posted (Actual)

March 10, 2017

Study Record Updates

Last Update Posted (Actual)

March 13, 2017

Last Update Submitted That Met QC Criteria

March 10, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • Postgraduation Thesis
  • DRKS00011324 (Registry Identifier: The German Clinical Trials Register -Deutsche Register Klinischer Studien)
  • ChiCTR-OOC-16010171 (Registry Identifier: Chinese Clinical Trial Registry-ChiCTR)
  • UMIN000024722 (Registry Identifier: UMIN Clinical Trials Registry (UMIN-CTR))
  • U1111-1189-6165 (Registry Identifier: International Clinical Trials Registry Platform (ICTRP))
  • TCTR20161221005 (Registry Identifier: Thai Clinical Trials Registry (TCTR))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension, Pregnancy-Induced

Clinical Trials on clinical ophthalmoscopy

3
Subscribe